AU3300689A - Treatment of inflammatory disorders in humans - Google Patents

Treatment of inflammatory disorders in humans

Info

Publication number
AU3300689A
AU3300689A AU33006/89A AU3300689A AU3300689A AU 3300689 A AU3300689 A AU 3300689A AU 33006/89 A AU33006/89 A AU 33006/89A AU 3300689 A AU3300689 A AU 3300689A AU 3300689 A AU3300689 A AU 3300689A
Authority
AU
Australia
Prior art keywords
humans
treatment
inflammatory disorders
disorders
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU33006/89A
Other versions
AU616502B2 (en
Inventor
Michael Wellesley Dr. Whitehouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Publication of AU3300689A publication Critical patent/AU3300689A/en
Application granted granted Critical
Publication of AU616502B2 publication Critical patent/AU616502B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU33006/89A 1988-04-22 1989-04-14 Treatment of inflammatory disorders in humans Ceased AU616502B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI786888 1988-04-22
AUPI7868 1988-04-22

Publications (2)

Publication Number Publication Date
AU3300689A true AU3300689A (en) 1989-10-26
AU616502B2 AU616502B2 (en) 1991-10-31

Family

ID=3773040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33006/89A Ceased AU616502B2 (en) 1988-04-22 1989-04-14 Treatment of inflammatory disorders in humans

Country Status (5)

Country Link
AU (1) AU616502B2 (en)
DE (1) DE3913194A1 (en)
FR (1) FR2630648A1 (en)
GB (1) GB2217602A (en)
NZ (1) NZ228862A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE148344T1 (en) * 1990-04-27 1997-02-15 R Tech Ueno Ltd USE OF 15-DEHYDROXY-16-OXOPROSTAGLANDIN IN THE TREATMENT OF ALLERGY DISEASES
US5302617A (en) * 1990-04-27 1994-04-12 Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DE4022815A1 (en) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topical preparation contg. omega-3-fatty acids - for prophylaxis and treatment of skin inflammation e.g. eczema, burns, acene, contact allergies etc.
DE4042437A1 (en) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topical compsn. for treating burns - contg. omega-3-fatty acid esp. eicosa-penta:enoic acid as fish oil component, providing rapid healing
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
GB9323808D0 (en) * 1993-11-18 1994-01-05 Alpha Healthcare Ltd Composition containing zinc for the treatment of skin disorders
DE4439930C2 (en) * 1994-11-08 1996-10-10 Hudelmaier Ulrike Device for pumping concrete
AU693312B2 (en) * 1995-01-18 1998-06-25 Taisho Pharmaceutical Co., Ltd. Remedy for dermatitis
FR2740335B1 (en) * 1995-10-26 1997-12-19 Oreal USE OF LANTHANIDE, LITHIUM, TIN, ZINC, MANGANESE OR YTTRIUM SALT AS A SUBSTANCE P ANTAGONIST
CA2303833A1 (en) * 1997-07-18 1999-01-28 Patrick D. Kelly Genital lubricants with zinc to reduce irritation and allergic reactions
JP2003089647A (en) * 1999-03-10 2003-03-28 Takada Seiyaku Kk Articular disease therapeutic agent
GB9918023D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
CN1642540A (en) 2002-03-26 2005-07-20 东弗吉尼亚医学院 Suramin and derivatives thereof as topical microbicide and contraceptive
FR2873295B1 (en) * 2004-07-26 2006-12-01 Expanscience Sa Lab USE OF AT LEAST ONE CONJUGATED FATTY ACID TRIENE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF INFLAMMATION
US20090182050A1 (en) * 2005-10-07 2009-07-16 Ocean Nutrition Canada, Ltd. Salts of Fatty Acids and Methods of Making and Using thereof
CN108623448B (en) * 2018-05-15 2019-04-05 南京医科大学 Linolenic acid zinc preparation and its preparing the application in Anti-helicobacter pylori drugs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB798655A (en) * 1956-03-15 1958-07-23 Biorex Laboratories Ltd Improvements in or relating to therapeutic compositions
GB943282A (en) * 1960-10-13 1963-12-04 Peter James Shannon Hair restorer
FR2406775A1 (en) * 1977-10-19 1979-05-18 Fmc Europe QUICK DISCONNECT COUPLING DEVICE FOR CRYOGENIC APPLICATIONS
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
JPS5529524A (en) * 1978-08-21 1980-03-01 Toyo Aerosol Kogyo Kk Powdery aerosol composition
JPH0256337B2 (en) * 1980-11-24 1990-11-29 Rejinarudo Mooton Teiraa
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
WO1986000251A1 (en) * 1984-06-22 1986-01-16 The Taylor-Winfield Corporation Robot welder
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
GB2191941B (en) * 1985-08-27 1990-03-14 Glyzinc Pharma Ltd Zinc glycerolate complex and additions for pharmaceutical applications

Also Published As

Publication number Publication date
GB2217602A (en) 1989-11-01
GB8908831D0 (en) 1989-06-07
NZ228862A (en) 1991-03-26
DE3913194A1 (en) 1989-11-02
AU616502B2 (en) 1991-10-31
FR2630648A1 (en) 1989-11-03

Similar Documents

Publication Publication Date Title
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU4081489A (en) Fatty acid therapy and compositions
AU3300689A (en) Treatment of inflammatory disorders in humans
AU4342989A (en) Mercapto-acylamino acids useful in the treatment of cardiovascular disorders and as analgesics
AU3236093A (en) The use of ob-101 to treat inflammation
AU3235693A (en) The use of ob-104 to treat inflammation
AU3604289A (en) Treatment of arthritis
AU1279788A (en) Compounds and treatment
AU576901B2 (en) Pain treatments in human joints
AU3790489A (en) Composition and method for treatment of gastrointestinal disorders
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
AU3553489A (en) Novel compounds and treatment
AU3434489A (en) Skin treatment formulations
AU584120B2 (en) Topical treatment of skin inflammatory disorders
GB8912373D0 (en) Medicament for various skin and ulcer disorders
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU3554089A (en) Compositions and methods for treating cutaneous hyperproliferative disorders
AU8083591A (en) Therapy and prophylaxis of autoimmune diseases
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
AU4834990A (en) Formulations for treating slow and non-healing wounds
ZA944671B (en) Medicaments for the treatment of inflammatory diseases